dehydroepiandrosterone has been researched along with Congenital Adrenal Hyperplasia in 145 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess whether patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency exhibit a steroidogenic response to GnRH agonist consistent with functional ovarian hyperandrogenism (FOH) and elucidate the relationship between adrenal and ovarian hyperandrogenism, the LH, FSH, estradiol, 17-hydroxyprogesterone (17-OHP), androstenedione, total testosterone, dehydroepiandrosterone, and 17-hydroxypregnenolone responses to a sc dose of leuprolide acetate (500 micrograms) were evaluated in 10 patients with classic CAH (mean age, 18." | 7.69 | Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. ( Bernasconi, S; Cappa, M; Ghizzoni, L; Ibañez, L; Street, ME; Virdis, R; Vottero, A; Zampolli, M, 1996) |
| "To determine whether measurements of plasma dehydroepiandrosterone (DHEA) sulfate and ACTH stimulation tests, both widely used in the evaluation of hirsutism in women, provide useful information, we performed both tests in 22 normal women and 31 female patients with hirsutism." | 7.68 | ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism. ( Finegold, DN; Lanes, R; Lee, PA; Siegel, SF, 1990) |
| "The practicability and tolerability of trilostane, a competitive inhibitor of 3 beta-hydroxysteroid-delta 5-dehydrogenase, for the therapy of primary aldosteronism was assessed in 1 patient with aldosterone-producing adenoma (APA) and 3 subjects with idiopathic adrenal hyperplasia (IHA)." | 7.67 | Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor). ( Ishikawa, S; Katayama, T; Kazama, T; Koike, H; Nakada, T; Yoshikawa, M, 1985) |
| "Serum concentrations of dehydroepiandrosterone sulfate (DHEAS) were measured in 28 patients (18 females, 10 males) with congenital adrenal hyperplasia due to 21-hydroxylase deficiency who were treated with oral hydrocortisone (non-salt losers) or hydrocortisone and 9-alpha-fluorohydrocortisone (salt-losers)." | 7.66 | Disproportionate suppression of dehydroepiandrosterone sulfate (DHEAS) in treated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. ( Artman, HG; Digeorge, AM; Garibaldi, LR; Rezvani, I, 1983) |
| "The effects of prednisone therapy and the withdrawal of prednisone for 3 days on hormonal relationships was investigated in 6 adolescent patients, age 10--19 years with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency." | 7.66 | Hormonal and clinical responses to prednisone treatment in adolescents with congenital adrenal hyperplasia. ( Bacon, GE; Kelch, RP; Zipf, WB, 1980) |
| "Treatment outcome in congenital adrenal hyperplasia is often suboptimal due to hyperandrogenism, treatment-induced hypercortisolism, or both." | 6.68 | A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia. ( Barnes, KM; Cutler, GB; Hill, S; Jones, JV; Laue, L; Merke, DP, 1996) |
| "Non-classic congenital adrenal hyperplasia (NC-CAH), one of the most common genetic disorders, is often associated with the clinical features of hyperandrogenism." | 5.40 | The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia. ( Krysiak, R; Okopien, B, 2014) |
| "Non-classic congenital adrenal hyperplasia (NC-CAH) is one of the most frequent genetic disorders and its presence often results in androgen excess." | 5.39 | The effect of simvastatin treatment on plasma steroid levels in females with non-classic congenital adrenal hyperplasia. ( Krysiak, R; Okopien, B, 2013) |
| " The frequency of obesity and the correlation between dehydroepiandrosterone sulphate levels and body mass index suggest that body weight is involved in the onset of adrenarche." | 3.72 | Premature pubarche as an indicator of how body weight influences the onset of adrenarche. ( Brauner, R; Charkaluk, ML; Trivin, C, 2004) |
| "Dehydroepiandrosterone sulfate (DHEAS) concentration levels were measured by a specific RIA in 23 female and 7 male patients with classical congenital adrenal hyperplasia (CAH) salt-losing type due to steroid 21-hydroxylase (21-OH) deficiency." | 3.69 | Blunted adrenarche in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. ( MacGillivray, MH; Sellers, EP, 1995) |
| "To assess whether patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency exhibit a steroidogenic response to GnRH agonist consistent with functional ovarian hyperandrogenism (FOH) and elucidate the relationship between adrenal and ovarian hyperandrogenism, the LH, FSH, estradiol, 17-hydroxyprogesterone (17-OHP), androstenedione, total testosterone, dehydroepiandrosterone, and 17-hydroxypregnenolone responses to a sc dose of leuprolide acetate (500 micrograms) were evaluated in 10 patients with classic CAH (mean age, 18." | 3.69 | Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. ( Bernasconi, S; Cappa, M; Ghizzoni, L; Ibañez, L; Street, ME; Virdis, R; Vottero, A; Zampolli, M, 1996) |
| " The degree of hirsutism, the menstrual abnormalities and the level of 17-ketosteroids, of DHEA, of 17-OH-corticoids in urine and RIA of total and free testosterone and of sex binding globulins (SHBG) in blood were performed." | 3.68 | [Endocrine and ultrasound examination of hirsutism]. ( Baron, JJ, 1991) |
| "To determine whether measurements of plasma dehydroepiandrosterone (DHEA) sulfate and ACTH stimulation tests, both widely used in the evaluation of hirsutism in women, provide useful information, we performed both tests in 22 normal women and 31 female patients with hirsutism." | 3.68 | ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism. ( Finegold, DN; Lanes, R; Lee, PA; Siegel, SF, 1990) |
| "We investigated the value of serum levels of adrenal steroids (dehydroepiandrosterone sulphate, testosterone, 17-hydroxyprogesterone, cortisol) in the identification in peripubertal females with late-onset congenital adrenal hyperplasia owing to 21-hydroxylase deficiency." | 3.67 | Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization. ( Gács, G; Keszei, K; Láng, K; Orley, J; Petheö, I; Ságodi, L; Sólyom, J, 1987) |
| "The practicability and tolerability of trilostane, a competitive inhibitor of 3 beta-hydroxysteroid-delta 5-dehydrogenase, for the therapy of primary aldosteronism was assessed in 1 patient with aldosterone-producing adenoma (APA) and 3 subjects with idiopathic adrenal hyperplasia (IHA)." | 3.67 | Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor). ( Ishikawa, S; Katayama, T; Kazama, T; Koike, H; Nakada, T; Yoshikawa, M, 1985) |
| "Serum concentrations of dehydroepiandrosterone sulfate (DHEAS) were measured in 28 patients (18 females, 10 males) with congenital adrenal hyperplasia due to 21-hydroxylase deficiency who were treated with oral hydrocortisone (non-salt losers) or hydrocortisone and 9-alpha-fluorohydrocortisone (salt-losers)." | 3.66 | Disproportionate suppression of dehydroepiandrosterone sulfate (DHEAS) in treated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. ( Artman, HG; Digeorge, AM; Garibaldi, LR; Rezvani, I, 1983) |
| " Based on their experience, the authors suggest an inexpensive investigative strategy in hyperandrogenic females consisting of the following: the first step depends upon the clinical symptoms--in cases of hirsutism with regular menstrual cycles, plasma testosterone (T) and plasma dehydroepiandrosterone sulfate (DHA-S) are assayed, and the basal body temperature chart is recorded." | 3.66 | Investigative strategy of hyperandrogenism in women. ( Buvat, J; Buvat-Herbaut, M; Dewailly, D; Fossati, P; Marcolin, G; Racadot, A, 1983) |
| "Plasma levels of dehydroepiandrosterone-sulfate (DHEA-S), dehydroepiandrosterone (DHEA), delta 4-androstenedione (delta 4), testosterone and 17 alpha-OH-progesterone (17-OH-P) were studied in 58 samples collected in 18 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, during long-term ambulatory treatment with hydrocortisone." | 3.66 | Plasma levels of androgens and 17 alpha-OH-progesterone as an index of the adequacy of treatment in congenital adrenal hyperplasia. ( Eeckels, R; Eggermont, E; Ilondo, MM; Malvaux, P; Pizarro, M; Vanderschueren-Lodeweyckx, M; Vlietinck, R, 1983) |
| "Serum androgen levels, including dehydroepiandrosterone sulphate (DHAS) which is thought to be solely of adrenal origin, are elevated in women with the polycystic ovarian syndrome." | 3.66 | Acth function in women with the polycystic ovarian syndrome. ( Butt, WR; Holder, G; Horrocks, PM; Kandeel, FR; Logan-Edwards, R; London, DR; Lynch, SS, 1983) |
| "The effects of prednisone therapy and the withdrawal of prednisone for 3 days on hormonal relationships was investigated in 6 adolescent patients, age 10--19 years with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency." | 3.66 | Hormonal and clinical responses to prednisone treatment in adolescents with congenital adrenal hyperplasia. ( Bacon, GE; Kelch, RP; Zipf, WB, 1980) |
| "Treatment outcome in congenital adrenal hyperplasia is often suboptimal due to hyperandrogenism, treatment-induced hypercortisolism, or both." | 2.68 | A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia. ( Barnes, KM; Cutler, GB; Hill, S; Jones, JV; Laue, L; Merke, DP, 1996) |
| " Chronic administration of long acting GnRH agonists (GnRHa), like continuous infusion of high doses of the native peptide, results in suppression of pituitary gonadotropin secretion." | 2.37 | Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. ( Bode, HH; Boepple, PA; Crawford, JD; Crigler, JF; Crowley, WF; Mansfield, MJ; Rudlin, CR; Wierman, ME, 1986) |
| "We present a female patient with congenital adrenal hyperplasia detected in newborn screening due to elevated 17OH-progesterone." | 1.43 | Non-Virilizing Congenital Adrenal Hyperplasia in a Female Patient with a Novel HSD3B2 Mutation. ( Camats, N; Flück, CE; l'Allemand, D; Probst-Scheidegger, U; Udhane, SS, 2016) |
| "The treatment goal in congenital adrenal hyperplasia (CAH) is to replace glucocorticoids while avoiding androgen excess and iatrogenic Cushing's syndrome." | 1.42 | Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers. ( Backlund, PS; Crutchfield, CA; Debono, M; Gounden, V; Harrison, RF; Mallappa, A; Merke, DP; Nella, AA; Ross, RJ; Soldin, SJ, 2015) |
| "Non-classic congenital adrenal hyperplasia (NC-CAH), one of the most common genetic disorders, is often associated with the clinical features of hyperandrogenism." | 1.40 | The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia. ( Krysiak, R; Okopien, B, 2014) |
| "Non-classic congenital adrenal hyperplasia (NC-CAH) is one of the most frequent genetic disorders and its presence often results in androgen excess." | 1.39 | The effect of simvastatin treatment on plasma steroid levels in females with non-classic congenital adrenal hyperplasia. ( Krysiak, R; Okopien, B, 2013) |
| "Some research suggests that girls with congenital adrenal hyperplasia (CAH), who are exposed to higher than normal levels of prenatal androgens, perform better on spatial tasks, worse on verbal tasks and have a greater incidence of left-handedness than unaffected controls, all of which suggests the development of a more male-typical cognitive pattern." | 1.33 | Cognitive outcome in adult women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency. ( Carson, KA; Malouf, MA; Migeon, CJ; Petrucci, L; Wisniewski, AB, 2006) |
| "Testicular tumors are very rare in boys, approximately 1." | 1.31 | [Precocious puberty caused by a testicular Leydig cell tumor]. ( Borbás, E; Minik, K; Réti, G; Ságodi, L; Sólyom, E, 2001) |
| "Late-onset congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency has been reported with increasing frequency, but only a few adult women have been found to have this disorder in Japan." | 1.29 | A case of late-onset congenital adrenal hyperplasia due to partial 3 beta-hydroxysteroid dehydrogenase deficiency. ( Hattori, N; Hino, M; Ikekubo, K; Ishihara, T; Kurahachi, H; Moridera, K, 1993) |
| "The patient was diagnosed with congenital adrenal hyperplasia (CAH) and received hormone therapy." | 1.29 | Hormonal and genetic analysis of a patient with congenital adrenal hyperplasia. ( Herold, DA; Seely, BL; Summers, RH, 1996) |
| "When dehydroepiandrosterone was used as substrate, the Km value for G129R3 beta HSD was 14 +/- 2 mumol/L compared with 2." | 1.29 | Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency. ( Chang, YT; Labrie, F; Pang, S; Rhéaume, E; Sanchez, R; Simard, J; Wang, J, 1994) |
| "We present an unusual patient with a Leydig cell tumor to show that greatly elevated serum concentrations of 17-hydroxyprogesterone (17OHP) may not be diagnostic of congenital adrenal hyperplasia (CAH)." | 1.28 | Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia. ( Goldsmith, MA; Miller, WL; Solish, SB; Voutilainen, R, 1989) |
| "The occurrence of nonclassical congenital adrenal hyperplasia among children with precocious pubarche is still a matter of debate." | 1.28 | Adrenal steroidogenic defects in children with precocious pubarche. ( Borrelli, P; Cambiaso, P; Cappa, M; Danielli, E; del Balzo, P, 1992) |
| "The male pseudohermaphroditism resulted from deficient testosterone synthesis due to deficiency of 17 alpha-hydroxylase and 17,20 desmolase." | 1.27 | Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. ( Gautier, T; Imperato-McGinley, J; Peterson, RE; Shackleton, C, 1985) |
| "In four patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase (21-OHase) deficiency, ASI and plasma concentrations of pre-defect steroid were determined." | 1.27 | Age-related changes in adrenal size during the first year of life in normal newborns, infants and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: comparison of ultrasound and hormonal parameters. ( Hauffa, BP; Menzel, D; Stolecke, H, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 79 (54.48) | 18.7374 |
| 1990's | 41 (28.28) | 18.2507 |
| 2000's | 11 (7.59) | 29.6817 |
| 2010's | 13 (8.97) | 24.3611 |
| 2020's | 1 (0.69) | 2.80 |
| Authors | Studies |
|---|---|
| Jing, H | 1 |
| Ding, Y | 1 |
| Jiang, X | 1 |
| Liu, G | 1 |
| Sha, Y | 1 |
| Medeiros, SF | 1 |
| Gil-Junior, AB | 1 |
| Barbosa, JS | 1 |
| Isaías, ED | 1 |
| Yamamoto, MM | 1 |
| Krysiak, R | 2 |
| Okopien, B | 2 |
| Turcu, AF | 1 |
| Auchus, RJ | 3 |
| Debono, M | 1 |
| Mallappa, A | 1 |
| Gounden, V | 2 |
| Nella, AA | 1 |
| Harrison, RF | 1 |
| Crutchfield, CA | 1 |
| Backlund, PS | 1 |
| Soldin, SJ | 2 |
| Ross, RJ | 1 |
| Merke, DP | 3 |
| Stolze, BR | 1 |
| Gu, J | 1 |
| Elliott, EA | 1 |
| Masika, LS | 1 |
| Abel, BS | 1 |
| Skarulis, MC | 1 |
| Probst-Scheidegger, U | 1 |
| Udhane, SS | 1 |
| l'Allemand, D | 1 |
| Flück, CE | 1 |
| Camats, N | 1 |
| Khoury, K | 1 |
| Barbar, E | 1 |
| Ainmelk, Y | 1 |
| Ouellet, A | 1 |
| Lehoux, JG | 1 |
| Lee, CT | 1 |
| Tung, YC | 1 |
| Hsiao, PH | 1 |
| Lee, JS | 1 |
| Tsai, WY | 1 |
| Chang, AY | 1 |
| Ashida, K | 1 |
| Akehi, Y | 1 |
| Kudo, T | 1 |
| Yanase, T | 1 |
| Ghayee, HK | 1 |
| Rege, J | 1 |
| Watumull, LM | 1 |
| Nwariaku, FE | 1 |
| Carrick, KS | 1 |
| Rainey, WE | 1 |
| Miller, WL | 5 |
| Kamrath, C | 1 |
| Hartmann, MF | 1 |
| Wudy, S | 1 |
| Oswiecimska, JM | 1 |
| Ksiazek, A | 1 |
| Sygulla, K | 1 |
| Pys-Spychala, M | 1 |
| Roczniak, GR | 1 |
| Roczniak, W | 1 |
| Stojewska, M | 1 |
| Ziora, K | 1 |
| Cutolo, M | 1 |
| Sulli, A | 1 |
| Pizzorni, C | 1 |
| Craviotto, C | 1 |
| Prete, C | 1 |
| Foppiani, L | 1 |
| Salvarani, C | 1 |
| Straub, RH | 1 |
| Seriolo, B | 1 |
| NATOLI, A | 1 |
| MAGLIOCCA, R | 1 |
| GOLDZIEHER, JW | 1 |
| DIGNAM, WJ | 1 |
| PION, RJ | 1 |
| LAMB, EJ | 1 |
| SIMMER, HH | 1 |
| VILLEE, DB | 1 |
| SORCINI, G | 1 |
| SCIARRA, F | 1 |
| CONCOLINO, G | 1 |
| RASCIO, L | 1 |
| MORTIMER, JG | 1 |
| RUDD, BT | 1 |
| BUTT, WR | 2 |
| ROSNER, JM | 1 |
| CONTE, NF | 1 |
| BRIGGS, JH | 1 |
| CHAO, PY | 1 |
| SUDMAN, EM | 1 |
| FORSHAM, PH | 1 |
| Charkaluk, ML | 1 |
| Trivin, C | 1 |
| Brauner, R | 1 |
| Goto, K | 1 |
| Nawata, H | 2 |
| Malouf, MA | 1 |
| Migeon, CJ | 3 |
| Carson, KA | 1 |
| Petrucci, L | 1 |
| Wisniewski, AB | 1 |
| Fanta, M | 1 |
| Cibula, D | 1 |
| Vrbíková, J | 1 |
| Riad-Fahmy, D | 1 |
| Read, GF | 1 |
| Walker, RF | 1 |
| Griffiths, K | 1 |
| Rezvani, I | 1 |
| Garibaldi, LR | 2 |
| Digeorge, AM | 1 |
| Artman, HG | 1 |
| Braithwaite, SS | 1 |
| Jabamoni, R | 1 |
| Buvat, J | 1 |
| Dewailly, D | 3 |
| Marcolin, G | 1 |
| Buvat-Herbaut, M | 1 |
| Racadot, A | 2 |
| Fossati, P | 2 |
| Ilondo, MM | 1 |
| Vanderschueren-Lodeweyckx, M | 1 |
| Pizarro, M | 1 |
| Vlietinck, R | 1 |
| Malvaux, P | 1 |
| Eggermont, E | 1 |
| Eeckels, R | 1 |
| Check, JH | 1 |
| Krotec, JW | 1 |
| Roger, M | 1 |
| Chaussain, JL | 1 |
| Evain, D | 1 |
| Toublanc, JE | 1 |
| Canlorbe, P | 1 |
| Scholler, R | 1 |
| Tóth, I | 1 |
| Faredin, I | 1 |
| Zacharías, S | 1 |
| Contreras, P | 1 |
| New, MI | 8 |
| Levine, LS | 8 |
| Dupont, B | 3 |
| Lorenzen, F | 3 |
| Pang, S | 7 |
| Pollack, M | 2 |
| Oberfield, SE | 2 |
| Kohn, B | 2 |
| Lerner, A | 2 |
| Cacciari, E | 3 |
| Mantero, F | 2 |
| Cassio, A | 2 |
| Scaroni, C | 2 |
| Chiumello, G | 3 |
| Rondanini, GF | 2 |
| Gargantini, L | 2 |
| Giovannelli, G | 2 |
| Virdis, R | 4 |
| Bartolotta, E | 2 |
| Migliori, C | 2 |
| Pintor, C | 2 |
| Tato, L | 2 |
| Barboni, F | 2 |
| Horrocks, PM | 2 |
| London, DR | 2 |
| Kandeel, FR | 1 |
| Lynch, SS | 1 |
| Holder, G | 1 |
| Logan-Edwards, R | 1 |
| Gangemi, M | 1 |
| Benato, M | 1 |
| Guacci, AM | 1 |
| Meneghetti, G | 1 |
| Zipf, WB | 1 |
| Bacon, GE | 1 |
| Kelch, RP | 1 |
| Cederqvist, LL | 1 |
| Fuentes, M | 1 |
| Riccardi, VM | 1 |
| Holcombe, JH | 2 |
| Nitowsky, HM | 1 |
| Sachs, G | 1 |
| Anderson, CE | 1 |
| Duchon, MA | 1 |
| Owens, R | 1 |
| Merkatz, I | 1 |
| Oberfield, S | 1 |
| Elias, AN | 1 |
| Grossman, MK | 1 |
| Meshkinpour, H | 1 |
| Valenta, LJ | 1 |
| Bernick, D | 1 |
| Mauvais-Jarvis, P | 1 |
| Kuttenn, F | 1 |
| Mowszowicz, I | 1 |
| de Peretti, E | 1 |
| Forest, MG | 2 |
| Sellers, EP | 1 |
| MacGillivray, MH | 1 |
| Ibáñez, L | 2 |
| Bonnin, MR | 1 |
| Zampolli, M | 2 |
| Prat, N | 1 |
| Alia, PJ | 1 |
| Navarro, MA | 1 |
| Brunelli, VL | 1 |
| David, M | 1 |
| Likitmaskul, S | 1 |
| Cowell, CT | 1 |
| Donaghue, K | 1 |
| Kreutzmann, DJ | 1 |
| Howard, NJ | 1 |
| Blades, B | 1 |
| Silink, M | 1 |
| Del Monte, P | 1 |
| Bernasconi, D | 1 |
| Bertolazzi, L | 1 |
| Meozzi, M | 1 |
| Badaracco, B | 1 |
| Torre, R | 1 |
| Marugo, M | 1 |
| De Raeve, L | 1 |
| De Schepper, J | 1 |
| Smitz, J | 1 |
| Paula, FJ | 1 |
| Gouveia, LM | 1 |
| Paccola, GM | 1 |
| Piccinato, CE | 1 |
| Moreira, AC | 1 |
| Foss, MC | 1 |
| Hattori, N | 1 |
| Ishihara, T | 1 |
| Moridera, K | 1 |
| Hino, M | 1 |
| Ikekubo, K | 1 |
| Kurahachi, H | 1 |
| Rhéaume, E | 1 |
| Sanchez, R | 1 |
| Simard, J | 1 |
| Chang, YT | 2 |
| Wang, J | 1 |
| Labrie, F | 2 |
| Warenik-Szymankiewicz, A | 1 |
| Baron, JJ | 3 |
| Zmich, C | 1 |
| Baron, J | 2 |
| Balducci, R | 1 |
| Boscherini, B | 1 |
| Mangiantini, A | 1 |
| Morellini, M | 1 |
| Toscano, V | 1 |
| Young, J | 1 |
| Couzinet, B | 1 |
| Pholsena, M | 1 |
| Nahoul, K | 1 |
| Schaison, G | 1 |
| Azziz, R | 5 |
| Bradley, EL | 2 |
| Potter, HD | 2 |
| Boots, LR | 4 |
| Izumi, H | 1 |
| Saito, N | 1 |
| Ichiki, S | 1 |
| Makino, Y | 1 |
| Yukitake, K | 1 |
| Kaneoka, T | 1 |
| Ghizzoni, L | 1 |
| Vottero, A | 1 |
| Cappa, M | 2 |
| Street, ME | 2 |
| Bernasconi, S | 1 |
| Terzolo, M | 1 |
| Osella, G | 1 |
| Alì, A | 1 |
| Borretta, G | 1 |
| Magro, GP | 1 |
| Termine, A | 1 |
| Paccotti, P | 1 |
| Angeli, A | 1 |
| Summers, RH | 1 |
| Herold, DA | 1 |
| Seely, BL | 1 |
| Laue, L | 1 |
| Jones, JV | 1 |
| Barnes, KM | 1 |
| Hill, S | 1 |
| Cutler, GB | 1 |
| Sakkal-Alkaddour, H | 1 |
| Zhang, L | 1 |
| Yang, X | 1 |
| Kappy, M | 1 |
| Slover, RS | 1 |
| Jorgensen, V | 1 |
| Weber, A | 1 |
| Camacho-Hübner, C | 1 |
| Perry, LA | 2 |
| Brain, CE | 1 |
| Cotterill, AM | 1 |
| Savage, MO | 1 |
| Salinas Vert, I | 1 |
| Audí Parera, L | 1 |
| Granada Ybern, ML | 1 |
| Lucas Martín, A | 1 |
| Pizarro Lozano, E | 1 |
| Foz Sala, M | 1 |
| Sanmartí Sala, A | 1 |
| Erel, CT | 1 |
| Senturk, LM | 1 |
| Oral, E | 1 |
| Mutlu, H | 1 |
| Colgar, U | 1 |
| Seyisoglu, H | 1 |
| Ertungealp, E | 1 |
| Moran, C | 2 |
| Reyna, R | 2 |
| Huerta, R | 1 |
| Decanter, C | 1 |
| Knochenhauer, ES | 1 |
| Ságodi, L | 2 |
| Borbás, E | 1 |
| Réti, G | 1 |
| Minik, K | 1 |
| Sólyom, E | 1 |
| Sánchez, LA | 1 |
| Ochoa, T | 1 |
| Maclaren, NK | 1 |
| Raiti, S | 1 |
| Bierich, JR | 1 |
| Gupta, D | 1 |
| Ferrante, L | 1 |
| Korth-Schutz, S | 1 |
| Saenger, P | 1 |
| Chow, DM | 2 |
| Keenan, BS | 1 |
| McNeel, R | 1 |
| Barrett, GN | 1 |
| Kirkland, RT | 1 |
| Clayton, GW | 1 |
| Faiman, C | 1 |
| Metcalf, MG | 1 |
| Gunczler, P | 1 |
| Hawkins, LA | 1 |
| Chasalow, FI | 1 |
| Blethen, SL | 1 |
| Jaresch, S | 1 |
| Kornely, E | 1 |
| Kley, HK | 1 |
| Schlaghecke, R | 1 |
| Bates, GW | 1 |
| French, GM | 1 |
| Humphries, BB | 1 |
| Blackhurst, DW | 1 |
| Akinci, A | 1 |
| Yordam, N | 1 |
| Ersoy, F | 1 |
| Uluşahin, N | 1 |
| Oğuz, H | 1 |
| Turner, EI | 1 |
| Watson, MJ | 1 |
| White, MC | 1 |
| del Balzo, P | 1 |
| Borrelli, P | 1 |
| Cambiaso, P | 1 |
| Danielli, E | 1 |
| Augarten, A | 1 |
| Pariente, C | 1 |
| Gazit, E | 1 |
| Chayen, R | 1 |
| Goldfarb, H | 1 |
| Sack, J | 1 |
| Leite, MV | 1 |
| Mendonça, BB | 1 |
| Arnhold, IJ | 1 |
| Estefan, V | 1 |
| Nunes, C | 1 |
| Nicolau, W | 1 |
| Bloise, W | 1 |
| Riddick, LM | 1 |
| Wang, ME | 1 |
| Senne, AR | 1 |
| Klimah, PE | 1 |
| Clark, AT | 1 |
| Pang, SY | 1 |
| Rafi, A | 1 |
| Smith, BR | 1 |
| Zacur, HA | 1 |
| Dzenis, IG | 1 |
| Latypova, NKh | 1 |
| Kuznetsova, MN | 1 |
| Siegel, SF | 1 |
| Finegold, DN | 1 |
| Lanes, R | 1 |
| Lee, PA | 1 |
| Ehrmann, DA | 1 |
| Rosenfield, RL | 2 |
| Montalto, J | 1 |
| Funder, JW | 1 |
| Yong, AB | 1 |
| Whorwood, CB | 1 |
| Connelly, JF | 1 |
| Hague, WM | 1 |
| Honour, JW | 1 |
| Adams, J | 1 |
| Vecsei, P | 1 |
| Jacobs, HS | 1 |
| Ogo, A | 1 |
| Linder, B | 1 |
| Feuillan, P | 1 |
| Chrousos, GP | 1 |
| Solish, SB | 1 |
| Goldsmith, MA | 1 |
| Voutilainen, R | 1 |
| Vantyghem, MC | 1 |
| Lemaire, C | 1 |
| Dufosse, F | 1 |
| Cohen, I | 1 |
| Blanstein, J | 1 |
| Ben-Michael, R | 1 |
| Lunenfeld, B | 1 |
| Eshkol, A | 1 |
| Peterson, RE | 1 |
| Imperato-McGinley, J | 1 |
| Gautier, T | 1 |
| Shackleton, C | 1 |
| Hammerstein, J | 1 |
| Boepple, PA | 1 |
| Mansfield, MJ | 1 |
| Wierman, ME | 1 |
| Rudlin, CR | 1 |
| Bode, HH | 1 |
| Crigler, JF | 1 |
| Crawford, JD | 1 |
| Crowley, WF | 1 |
| Youlton, R | 1 |
| Urdl, W | 1 |
| Schweditsch, MO | 1 |
| Kowatsch, AW | 1 |
| Tscherne, G | 1 |
| Pürstner, P | 1 |
| Haas, J | 1 |
| Hauffa, BP | 1 |
| Menzel, D | 1 |
| Stolecke, H | 1 |
| Nakada, T | 1 |
| Kazama, T | 1 |
| Koike, H | 1 |
| Yoshikawa, M | 1 |
| Ishikawa, S | 1 |
| Katayama, T | 1 |
| Dumić, M | 1 |
| Brkljacić, L | 1 |
| Mardesić, D | 1 |
| Plavsić, V | 1 |
| Lukenda, M | 1 |
| Kastelan, A | 1 |
| McKenna, TJ | 1 |
| Cunningham, SK | 1 |
| Loughlin, T | 1 |
| Benjamin, F | 1 |
| Deutsch, S | 1 |
| Saperstein, H | 1 |
| Seltzer, VL | 1 |
| Sólyom, J | 1 |
| Gács, G | 1 |
| Keszei, K | 1 |
| Láng, K | 1 |
| Orley, J | 1 |
| Petheö, I | 1 |
| Wolthers, BG | 1 |
| Volmer, M | 1 |
| van Seters, AP | 1 |
| Cara, JF | 1 |
| Moshang, T | 1 |
| Bongiovanni, AM | 1 |
| Marx, BS | 1 |
| Orlova, VG | 1 |
| Rivera, R | 1 |
| Dorfman, RI | 1 |
| Forchielli, E | 1 |
| Rivarola, MA | 1 |
| Saez, JM | 1 |
| Conly, PW | 1 |
| Sandberg, DH | 1 |
| Cleveland, WW | 1 |
| Kenny, FM | 1 |
| Hashida, Y | 1 |
| Askari, HA | 1 |
| Sieber, WH | 1 |
| Fetterman, GH | 1 |
| Vadász, E | 1 |
| Debreczeni, M | 1 |
| Nagy, T | 1 |
| Göbel, P | 4 |
| Osborn, RH | 1 |
| Yannone, ME | 1 |
| Bradbury, JT | 1 |
| Vaitukaitis, JL | 1 |
| Melby, JC | 1 |
| Cyran, J | 1 |
| Goldman, AS | 2 |
| Dallera, L | 1 |
| Tassoni, P | 1 |
| Cicognani, A | 1 |
| Miano, A | 1 |
| Schindler, H | 1 |
| Garmendia, F | 1 |
| Nicolis, GL | 1 |
| Gabrilove, JL | 1 |
| Blunck, W | 1 |
| Gleispach, H | 1 |
| Berger, H | 1 |
| Glatzl, J | 1 |
| Rössler, H | 1 |
| Loriaux, DL | 1 |
| Ruder, HJ | 1 |
| Lipsett, MB | 1 |
| Sanghvi, A | 1 |
| Wight, C | 1 |
| Serenko, A | 1 |
| Balachandran, R | 1 |
| Zachmann, M | 1 |
| Vollmin, JA | 1 |
| Murset, G | 1 |
| Curtius, HC | 1 |
| Prader, A | 1 |
| Takahara, J | 1 |
| Hashimoto, K | 1 |
| Ofuji, T | 1 |
| Horký, K | 1 |
| Kuchel, O | 1 |
| Gregorová, I | 1 |
| Stárka, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Novel Therapeutic Modality for Congenital Adrenal Hyperplasia[NCT00529841] | 7 participants (Actual) | Interventional | 2007-01-31 | Completed | |||
| A Mechanistic Examination of Continuous Cycle Oral Contractive Administration in Binge Eating[NCT04278755] | Phase 2 | 8 participants (Actual) | Interventional | 2020-09-24 | Terminated (stopped due to Halted prematurely due to COVID-19-related enrollment challenges.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The Behavioral Inhibition/Behavioral Activation questionnaire will be used to assess behavioural inhibition (BI). The minimum score on the BI subscale is 7, maximum 28. Greater scores indicate greater BI. Change is defined as the average change in BI from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
| Intervention | score on a scale (Mean) |
|---|---|
| Continuous OC | 1.43 |
"Binge eating will be measured using the 8-item binge eating subscale of the Eating Pathology Symptoms Inventory (EPSI), which measures features of binge eating (e.g., consumption of large quantities of food, mindless eating) on a 5-point Likert scale from never to very often. The EPSI scale is designed to assess behavior over the past 28 days. Items are summed for a scale score ranging from 0-32. Higher scores indicate more frequent experiences with binge eating behavior. Change is defined as the average change in the binge eating scale score from pre-intervention to intervention." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
| Intervention | score on a scale (Mean) |
|---|---|
| Continuous OC | -6.60 |
The Monetary Choice Questionnaire will be used to measure delay discounting. Participants will be asked to make a series of hypothetical choices between small, sooner (impulsive) vs. larger, later (self controlled) hypothetical monetary outcomes. k is a hyperbolic function with larger k values indicating more valuation of a larger delayed reward and smaller values indicating preference for more immediate, smaller rewards (more impulsivity). k can range from 0 to .25 with scores of .25 indicating complete valuation of the immediate reward and 0 indicating complete valuation of the larger, delayed reward. Change is defined as the average change in k from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
| Intervention | k value (Mean) |
|---|---|
| Continuous OC | .01 |
"Nucleus Accumbens (NAcc) reactivity to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
| Intervention | percentage signal change (Mean) |
|---|---|
| Continuous OC | .0423 |
"Prefrontal cortex reactivity to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
| Intervention | percentage signal change (Mean) |
|---|---|
| Continuous OC | .01 |
Sensitivity to Punishment/Sensitivity to Reward Questionnaire will be used to measure reward sensitivity. The reward sensitivity subscale will be used, which is rated on a true/false scale with scores ranging 0-24. Higher scores indicate more sensitivity to reward. Change is defined as the average change in reward sensitivity from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
| Intervention | score on a scale (Mean) |
|---|---|
| Continuous OC | 1.60 |
Binge eating frequency is based on a weekly diary of self-reported binge eating frequency. Participants were asked how many times during the past week they had a binge eating episode. Scores can range from 0 to infinity as frequency is self-reported as the number of binge eating episodes in the previous week. Higher scores indicate more episodes of binge eating. Change is defined as the average change in self-reported binge eating frequency from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
| Intervention | episodes/week (Mean) |
|---|---|
| Continuous OC | -0.43 |
"Dorsal striatum reactivity (defined as caudate signal intensity and putamen signal intensity) to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
| Intervention | percentage signal change (Mean) | |
|---|---|---|
| Caudate | Putamen | |
| Continuous OC | -.012 | .02 |
17 reviews available for dehydroepiandrosterone and Congenital Adrenal Hyperplasia
| Article | Year |
|---|---|
Adrenal steroidogenesis and congenital adrenal hyperplasia.
Topics: Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocortical Adenoma; Aldosterone; Andr | 2015 |
46,XX DSD: the masculinised female.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adult; An | 2010 |
[The alternative androgen synthesis pathway in humans].
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenal Hyperplasia, Con | 2013 |
Androgen biosynthesis from cholesterol to DHEA.
Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Androgens; Animals; Cholesterol; Cholesterol Side-C | 2002 |
Disorders of androgen synthesis--from cholesterol to dehydroepiandrosterone.
Topics: Adrenal Cortex; Adrenal Hyperplasia, Congenital; Androgens; Cholesterol; Cholesterol Side-Chain Clea | 2005 |
[DHEA, DHEA-S].
Topics: Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Biomarkers; Cushing | 2005 |
Steroids in saliva for assessing endocrine function.
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Age Factors; Breast Neoplasms; Child; Circadian | 1982 |
Hirsutism.
Topics: 17-Ketosteroids; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Androgen Antagonists; And | 1983 |
[Common and uncommon forms of female sexual precocity and their biological diagnosis].
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; | 1984 |
Hypertension of childhood with suppressed renin.
Topics: 18-Hydroxydesoxycorticosterone; 20-alpha-Dihydroprogesterone; Adolescent; Adrenal Cortex; Adrenal Hy | 1980 |
Hirsutism.
Topics: 17-Ketosteroids; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adrenal Gland Neoplasms; Adrenal Hyperplasia | 1981 |
Early steps in androgen biosynthesis: from cholesterol to DHEA.
Topics: Adrenal Hyperplasia, Congenital; Cholesterol; Cytochrome P-450 Enzyme System; Dehydroepiandrosterone | 1998 |
Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Bone Development; Child; Child, Preschool; Dehydroe | 1986 |
The adrenal cortex and virilization.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyper | 1985 |
Inhibition of 3 -hydroxy- 5 -steroid dehydrogenase.
Topics: Adrenal Hyperplasia, Congenital; Androstenes; Animals; Antibodies; Cell Differentiation; Dehydroepia | 1971 |
[Some diagnostic and therapeutic aspects of adrenal disorders in childhood (author's transl)].
Topics: Addison Disease; Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenal Hyperplasia, Congenital; A | 1973 |
Relationship of androgens to female hirsutism and infertility.
Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Androstenedione; Androstenols; Dehydroepiandrostero | 1973 |
4 trials available for dehydroepiandrosterone and Congenital Adrenal Hyperplasia
| Article | Year |
|---|---|
Colonic mucosal potential differences in the management of 21-hydroxylase deficiency.
Topics: Action Potentials; Adrenal Hyperplasia, Congenital; Adult; Aldosterone; Androstenedione; Clinical Tr | 1980 |
Usefulness of an ACTH test in the diagnosis of nonclassical 21-hydroxylase deficiency among children presenting with premature pubarche.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Age of O | 1995 |
A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Bone Dev | 1996 |
Effect of aminoglutethimide on urinary steroid excretion in patients with congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency.
Topics: 17-alpha-Hydroxypregnenolone; 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adrenal Hy | 1972 |
124 other studies available for dehydroepiandrosterone and Congenital Adrenal Hyperplasia
| Article | Year |
|---|---|
RNA-Seq reveals ACTH-induced steroid hormone pathway participating in goat adrenal gland response to castration.
Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Androgens; Animals; De | 2023 |
New insights into steroidogenesis in normo- and hyperandrogenic polycystic ovary syndrome patients.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adult; Case-Control S | 2013 |
The effect of simvastatin treatment on plasma steroid levels in females with non-classic congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Cholesterol; Dehydroepiandrost | 2013 |
The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Androgens; Blood Glucose; Dehy | 2014 |
Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.
Topics: 17-alpha-Hydroxyprogesterone; 5-alpha-Dihydroprogesterone; Adrenal Hyperplasia, Congenital; Adrenoco | 2015 |
An improved micro-method for the measurement of steroid profiles by APPI-LC-MS/MS and its use in assessing diurnal effects on steroid concentrations and optimizing the diagnosis and treatment of adrenal insufficiency and CAH.
Topics: Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Androgens; Androsterone; Chromatography, Liq | 2016 |
Non-Virilizing Congenital Adrenal Hyperplasia in a Female Patient with a Novel HSD3B2 Mutation.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Amino Acid Sequence; Dehydroepiandros | 2016 |
Gonadal function, first cases of pregnancy, and child delivery in a woman with lipoid congenital adrenal hyperplasia.
Topics: Adrenal Hyperplasia, Congenital; Androgens; Dehydroepiandrosterone; Estradiol; Female; Fetal Death; | 2009 |
Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Androstenedione; Dehydroepiandrostero | 2010 |
[DHEA, DHEA-S].
Topics: Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Cushing Syndrome; Dehydroepiandrosterone; | 2010 |
Clinical, biochemical, and molecular characterization of macronodular adrenocortical hyperplasia of the zona reticularis: a new syndrome.
Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adult; Blotting, Western; Dehydroepi | 2011 |
Androgens concentrations and second-to fourth-digit ratio (2D:4D) in girls with congenital adrenal hyperplasia (21-hydroxylase deficiency).
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Androgens; Androstenedion | 2012 |
Cortisol, dehydroepiandrosterone sulfate, and androstenedione levels in patients with polymyalgia rheumatica during twelve months of glucocorticoid therapy.
Topics: Adrenal Cortex; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Aged; Aging; Androsten | 2002 |
[Urinary elimination of 17-ketosteroids and dehydroisoandrosterone in patients with various endocrine diseases (Addison's disease, Cushing's disease, Cushing's syndrome, precocious puberty caused by congenital adrenal hyperplasia, acromegaly)].
Topics: 17-Ketosteroids; Acromegaly; Addison Disease; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperf | 1955 |
ORIGINS OF HIRSUTISM AND VIRILISM.
Topics: Adrenal Hyperplasia, Congenital; Adrenogenital Syndrome; Cushing Syndrome; Dehydroepiandrosterone; D | 1963 |
PLASMA ANDROGENS IN WOMEN. II. PATIENTS WITH POLYCYSTIC OVARIES AND HIRSUTISM.
Topics: Adrenal Hyperplasia, Congenital; Adrenogenital Syndrome; Androgens; Androsterone; Blood Chemical Ana | 1964 |
EFFECTS OF SUBSTRATES AND COFACTORS ON STEROID SYNTHESIS IN HYPERPLASTIC ADRENALS.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Glands; Adrenal Hyperplasia, Congenital; Carbon Isotope | 1964 |
[ADRENOGENITAL SYNDROME CAUSED BY CONGENITAL HYPERPLASIA OF THE ADRENAL CORTEX: PATHOGENETIC IMPORTANCE OF TESTOSTERONE].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenal Cortex; Adrenal Gland Diseases; Adre | 1964 |
A VIRILIZING ADRENAL TUMOR IN A PREPUBERTAL BOY.
Topics: 17-Ketosteroids; Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Cong | 1964 |
DETERMINATION OF URINARY TESTOSTERONE BY CHROMATOGRAPHY AND COLORIMETRY: FINDINGS IN NORMAL SUBJECTS AND IN PATIENTS WITH ENDOCRINE DISEASES.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenogenital Syndrome; Androg | 1965 |
Premature pubarche as an indicator of how body weight influences the onset of adrenarche.
Topics: Adrenal Hyperplasia, Congenital; Birth Weight; Body Weight; Child; Child, Preschool; Dehydroepiandro | 2004 |
Cognitive outcome in adult women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Topics: Adrenal Hyperplasia, Congenital; Adult; Aged; Androgens; Androstenedione; Cognition; Dehydroepiandro | 2006 |
Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Ho | 2008 |
Disproportionate suppression of dehydroepiandrosterone sulfate (DHEAS) in treated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Age Factors; Child; Dehydroepiandrosterone; Dehydroepia | 1983 |
Investigative strategy of hyperandrogenism in women.
Topics: Adrenal Hyperplasia, Congenital; Androgens; Cushing Syndrome; Dehydroepiandrosterone; Female; Gonado | 1983 |
Plasma levels of androgens and 17 alpha-OH-progesterone as an index of the adequacy of treatment in congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Androgens; Androstenedion | 1983 |
Virilizing congenital adrenal hyperplasia with normal dehydroepiandrosterone sulfate.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Aldehyde-Lyases; Child; Dehydroepiand | 1983 |
Metabolism and concentration of androgenic steroids in abdominal skin of hirsute women with androgenital syndrome.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Abdominal Muscles; Adolescent; Adrenal Hyperplasia, Cong | 1984 |
[Hirsutism secondary to congenital adrenal hyperplasia caused by a 21-hydroxylase deficiency of late onset. A clinical case].
Topics: 17-Ketosteroids; Adolescent; Adrenal Hyperplasia, Congenital; Dehydroepiandrosterone; Female; Hirsut | 1984 |
Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency.
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androstenedione; Ch | 1981 |
A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormo | 1982 |
Acth function in women with the polycystic ovarian syndrome.
Topics: Adolescent; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; And | 1983 |
Deficit of 21 beta-hydroxylase. Clinico-functional parameters.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocor | 1983 |
Hormonal and clinical responses to prednisone treatment in adolescents with congenital adrenal hyperplasia.
Topics: 17-Ketosteroids; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Child; Dehydroepiandrosterone; | 1980 |
Amniotic fluid concentrations of delta 5 and delta 4 steroids in fetuses with congenital adrenal hyperplasia due to 21 hydroxylase deficiency and in anencephalic fetuses.
Topics: 17-alpha-Hydroxypregnenolone; Adrenal Hyperplasia, Congenital; Amniotic Fluid; Androstenedione; Anen | 1980 |
Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxypregnenolone; Adolescent; Adrenal Hyperplasia, Congenital; Androstenedione; Child; C | 1980 |
Pitfalls in the etiological diagnosis of congenital adrenal hyperplasia in the early neonatal period.
Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Hyperplasia, Congenital; Androstenedione; Dehydroepiandrost | 1982 |
Blunted adrenarche in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Cortex; Adrenal Hyperplasia, Congenital; Adult; An | 1995 |
Adrenarche does not occur in treated patients with congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenal Hyperplasia, Congenital; Adrenocorticotropic H | 1995 |
'Exaggerated adrenarche' in children presenting with premature adrenarche.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Cortex Diseases; Adrenal Cortex | 1995 |
Increased 17 alpha-hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause or effect?
Topics: 17-alpha-Hydroxyprogesterone; Adenoma; Adrenal Cortex Function Tests; Adrenal Gland Neoplasms; Adren | 1995 |
Prepubertal acne: a cutaneous marker of androgen excess?
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Ho | 1995 |
Androgen-related effects on peripheral glucose metabolism in women with congenital adrenal hyperplasia.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgens; Androstenedione; Blood Glucose; Dehydroepiandrost | 1994 |
A case of late-onset congenital adrenal hyperplasia due to partial 3 beta-hydroxysteroid dehydrogenase deficiency.
Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult | 1993 |
Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency.
Topics: 3-Hydroxysteroid Dehydrogenases; Adolescent; Adrenal Hyperplasia, Congenital; Base Sequence; Dehydro | 1994 |
[Diagnosis and treatment of congenital adrenal hyperplasia in women].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adult; Dehydroepiandros | 1994 |
Isolated precocious pubarche: an approach.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Adrenal | 1994 |
Plasma 3 beta-hydroxy-delta 5-steroids in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Dehydroepiandrosterone; Dehydro | 1994 |
[Differential diagnosis of hirsutism in girls between 15-19 years old].
Topics: 17-Ketosteroids; Adolescent; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adult; Dehydroepiandro | 1993 |
3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Adrenal | 1993 |
Prenatal diagnosis of congenital lipoid adrenal hyperplasia.
Topics: Adrenal Hyperplasia, Congenital; Adult; Amniotic Fluid; Dehydroepiandrosterone; Dehydroepiandrostero | 1993 |
Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congeni | 1996 |
Different patterns of steroid secretion in patients with adrenal incidentaloma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adul | 1996 |
Hormonal and genetic analysis of a patient with congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Adult; Androstenedione | 1996 |
Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.
Topics: 17-alpha-Hydroxypregnenolone; 3-Hydroxysteroid Dehydrogenases; Adrenal Hyperplasia, Congenital; Adre | 1996 |
Treatment-induced hypoandrogenism in childhood and puberty in females with virilizing (21-hydroxylase deficiency) congenital adrenal hyperplasia.
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Child; Dehydroepiandrosterone; Female; Glucocorticoids; | 1996 |
Girls with virilisation in childhood: a diagnostic protocol for investigation.
Topics: Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Androgens; Child; Child, Preschool; Clini | 1997 |
[Defects of adrenal steroidogenesis in patients with hirsutism].
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Cortex Hormones; Adr | 1998 |
Results of the ACTH stimulation test in hirsute women.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Function Tests; Adrenal Hyperplasia, Congenital; Adreno | 1999 |
Prevalence of 3beta-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excess.
Topics: 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Adolescent; Adrenal Hyperplasia, Cong | 1999 |
Adrenocortical hyperresponsivity to adrenocorticotropic hormone: a mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Topics: 17-alpha-Hydroxypregnenolone; Adrenal Cortex; Adrenal Hyperplasia, Congenital; Adrenocorticotropic H | 2000 |
[Precocious puberty caused by a testicular Leydig cell tumor].
Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Child, Preschool; Dehydroepiandrostero | 2001 |
Adrenal progestogen and androgen production in 21-hydroxylase-deficient nonclassic adrenal hyperplasia is partially independent of adrenocorticotropic hormone stimulation.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocorticotropic H | 2002 |
Gynecomastia with congenital virilizing adrenal hyperplasia (11-beta-hydroxylase deficiency).
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Function Tests; Adrenal Hyperplasia, Cong | 1975 |
[Prenatal diagnosis of the congenital adrenogenital syndrome].
Topics: Adrenal Hyperplasia, Congenital; Dehydroepiandrosterone; Estriol; Female; Humans; Hydroxyprogesteron | 1975 |
[Complex biochemical aspects in virilizing adrenal gland syndromes].
Topics: Adrenal Hyperplasia, Congenital; Androsterone; Dehydroepiandrosterone; Etiocholanolone; Female; Huma | 1976 |
Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia.
Topics: 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Androgens; Androsten | 1978 |
Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenal Glands; Adrenal Hyperplasia, Congeni | 1979 |
Serum androgen concentrations in neonates and young infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Topics: Adrenal Hyperplasia, Congenital; Age Factors; Androgens; Androstenedione; Dehydroepiandrosterone; Fe | 1979 |
Dehydroepiandrosterone--sulphate in urine.
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocorticotropic | 1978 |
"Acquired" adrenal hyperplasia with 21-hydroxylase deficiency is not the same genetic disorders as congenital adrenal hyperplasia.
Topics: Adolescent; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Adrenocor | 1979 |
The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/oligomenorrhea.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adrenal Cortex; Adrenal Cortex Diseases; Ad | 1992 |
Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocortic | 1992 |
Outcome of corticotropin stimulation testing in women with androgen excess and ovulatory dysfunction.
Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Androgens; Dehydroepiandrosterone; Deh | 1992 |
The incidence of non-classical 21-hydroxylase deficiency in hirsute adolescent girls.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormo | 1992 |
Investigation of adrenal function in women with oligomenorrhoea and hirsutism (clinical PCOS) from the north-east of England using an adrenal stimulation test.
Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Cortex Function Tests; Adrenal Glands; Adrenal Hyperplasia, | 1992 |
Adrenal steroidogenic defects in children with precocious pubarche.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Adrenal Glands; | 1992 |
Ambiguous genitalia due to partial activity of cytochromes P450c17 and P450c21.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Androstenedione; Chorionic Gonadotrop | 1992 |
Identification of nonclassical 21-hydroxylase deficiency in girls with precocious pubarche.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Adrenocorticot | 1991 |
[Endocrine and ultrasound examination of hirsutism].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adult; Amenorrhea; Dehy | 1991 |
3 alpha-Androstanediol glucuronide in premature and normal pubarche.
Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Andro | 1991 |
On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenal Hyperplasia, Congenital; Adult; Androgens; And | 1990 |
[Clinical variants of virile form of congenital adrenocortical dysfunction].
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormo | 1990 |
ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congeni | 1990 |
Hirsutism--beyond the steroidogenic block.
Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Dehydroepiandrosterone; Dehydroepiandr | 1990 |
Serum levels of 5-androstene-3 beta,17 beta-diol sulphate, 5 alpha-androstane-3 alpha, 17beta-diol sulphate and glucuronide, in late onset 21-hydroxylase deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; A | 1990 |
Steroid responses to ACTH in women with polycystic ovaries.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; | 1989 |
[Clinical significance of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate analysis in endocrine tests of the adrenal cortex].
Topics: Adrenal Hyperplasia, Congenital; Age Factors; Aged; Aged, 80 and over; Circadian Rhythm; Cushing Syn | 1989 |
Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocorticotropic H | 1989 |
Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adrenocorticotropic | 1989 |
Screening heterozygotes for 21-hydroxylase deficiency among hirsute women: lack of utility of the adrenocorticotropin hormone test.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormo | 1988 |
Adrenal response to adrenocorticotropin stimulation in unexplained infertile women.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; D | 1988 |
Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone | 1985 |
[Current status of gynecologic hormone therapy. Hyperandrogen disorders].
Topics: Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; | 1985 |
[Congenital adrenal hyperplasia: 3 clinical forms in one family].
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Child; Dehydroepiandrosterone; Female | 1985 |
[Value of laboratory parameters in androgenization in the female with special reference to the "free androgen index"].
Topics: Adrenal Hyperplasia, Congenital; Adult; Alopecia; Amenorrhea; Androgens; Dehydroepiandrosterone; Fem | 1986 |
Age-related changes in adrenal size during the first year of life in normal newborns, infants and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: comparison of ultrasound and hormonal parameters.
Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Age Factors; Dehydroepiandrosterone; Dehydroepiandr | 1988 |
Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor).
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adreno | 1985 |
'Cryptic' form of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in the Yugoslav population.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; A | 1985 |
Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Dehydroe | 1986 |
Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormo | 1987 |
Detection of 3 beta-hydroxysteroid-dehydrogenase deficiency by urinary steroid profiling: solvolysis of urinary samples should be a necessary prerequisite.
Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Hyperplasia, Congenital; Adult; Chromatography, Gas; Dehydr | 1985 |
Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3-beta-hydroxysteroid dehydrogenase deficiency.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; 20-Hydroxysteroid Dehydrogenases; Adrena | 1985 |
[Use of the Fortherby method for determination of dehydroepiandrosterone in urine in the obstetric clinic].
Topics: 17-Ketosteroids; Abortion, Habitual; Adrenal Hyperplasia, Congenital; Dehydroepiandrosterone; Female | 1969 |
A modified method for the analysis of urinary 17-ketosteroids, pregnanediol and pregnanetriol by gas liquid chromatography in normal subjects and subjects with various endocrine disorders.
Topics: 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Androsterone; Chromatography, Gas; Cushing Syndrom | 1967 |
Studies of androgens in patients with congenital adrenal hyperplasia.
Topics: Adolescent; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adult; Androsterone; Carbon Isotopes; C | 1967 |
Steroid metabolism in premature pubarche and virilizing adrenal hyperplasia.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenal Hyperplasia, Congenital; Androgens; | 1967 |
Virilizing tumors of the adrenal cortex.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acne Vulgaris; Adenoma; Adrenal Gland Neoplasms; Adrenal | 1968 |
[On the differential diagnosis of hirsutism].
Topics: 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adult; Chiari-Frommel Syndrome; Chromatography; De | 1968 |
[Adrenal hirsutism (3-beta-hydroxysteroid dehydrogenase deficiency). Studies using chromatographic separation of the urinary 17-ketosteroid fraction. 3. On the differential diagnosis of adrenal hirsutism (M. Cushing, congenital adrenogenital syndrome)].
Topics: 17-Ketosteroids; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adre | 1968 |
Androgen studies in virilism secondary to an adrenal adenoma and to congenital adrenal hyperplasia.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Hy | 1969 |
Menstrual disorders associated with adrenal dysfunction.
Topics: 17-Ketosteroids; Addison Disease; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenal Glands; | 1969 |
[Gas chromatography determination of urinary pregnanediol and -triol and its significance for the differentiation of adrenal hirsutism in women].
Topics: 17-Ketosteroids; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Adult; C | 1969 |
Virilization of the external genitalia of the female rat fetus by dehydroepiandrosterone.
Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Animals; Dehydroepiandrosterone; Female; Fetus; Mal | 1970 |
[Various aspects of steroidogenesis in congenital adrenogenital syndrome with or without salt loss (determination of the urinary excretion of aldosterone, androsterone, etiocholanolone, dehydroisoandrosterone, 17-hydroxy-11-desoxycorticosterone, pregnaned
Topics: Adrenal Hyperplasia, Congenital; Aldosterone; Androgens; Androsterone; Child; Child, Preschool; Dehy | 1969 |
[Suprarenal virilism].
Topics: 17-Ketosteroids; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Dehydroep | 1970 |
The determination of urinary pregnanetriol and the neutral 17-ketosteroids by gas-liquid chromatography.
Topics: 17-Ketosteroids; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adre | 1971 |
[Congenital adrenal hyperplasia; 21-hydroxylase-deficiency combined with 17-desmolase-deficiency (author's transl)].
Topics: Adrenal Hyperplasia, Congenital; Androsterone; Chemical Phenomena; Chemistry; Dehydroepiandrosterone | 1974 |
Plasma steroids in congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxypregnenolone; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Androst | 1974 |
Gas-liquid chromatography of underivatized steroids: simultaneous determination of urinary 17-ketosteroids, pregnanediol, pregnanetriol, and pregnanetriolone.
Topics: 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Androsterone; Chromatography, Gas; Computers; Dehy | 1974 |
[Adrenal hirsutism (3beta-hydroxysteroid dehydrogenase deficiency). Studies using a chromatographic separation of the 17-ketosteroid fraction in the urine. 1. Dehydroepiandrosterone-forming adrenocortical adenoma].
Topics: 17-Ketosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocorticotro | 1967 |
[Adrenal hirsutism (3-beta-hydroxysteroid dehydrogenase deficiency). Studies using a chromatographic separation of the urinary 17-ketosteroid fraction. 2. Dehydroepiandrosterone-forming adrenal hyperplasia and constitutional hirsutism].
Topics: 17-Ketosteroids; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; An | 1967 |
Unusual type of congenital adrenal hyperplasia probably due to deficiency of 3-beta-hydroxysteroid dehydrogenase. Case report of a surviving girl and steroid studies.
Topics: 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Adrenocorticotropic | 1970 |
[Gas liquid chromatography analysis of urinary neutral steroid fractions in normal persons and patients with various diseases].
Topics: 17-Ketosteroids; Adrenal Gland Diseases; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormon | 1970 |